Why Hidden Fees Make Treatment Comparison Impossible
Ozempic vs Wegovy vs Mounjaro: The Hidden Fee Problem
When researching Ozempic vs Wegovy vs Mounjaro, many patients encounter misleading pricing from online pharmacies. Advertised prices often exclude mandatory consultation fees (£20-50), prescription charges (£15-30), and administration costs (£10-20). At EverydayMeds, our radical transparency means Wegovy costs exactly £79.99 for 0.25mg starter dose - no additional charges appear at checkout.
This pricing clarity becomes crucial when comparing Ozempic vs Wegovy vs Mounjaro long-term. Whilst Ozempic is licensed only for type 2 diabetes treatment, Wegovy (semaglutide) and Mounjaro (tirzepatide) are both MHRA-approved for weight management in adults with BMI ≥30, or BMI ≥27 with weight-related comorbidities. Hidden fees can add £40-100 per order, making genuine cost comparison impossible until checkout.
Wegovy vs Mounjaro Pricing: Complete Transparency
Our transparent pricing for Ozempic vs Wegovy vs Mounjaro comparison shows Wegovy single pens from £79.99 (0.25mg) to £209.99 (2.4mg maintenance), whilst our Consistency bundles offer convenient supply options. The Intro Duo (0.25mg & 0.5mg) costs £169.99, covering your first 8 weeks of treatment. New customers apply code FIRST40 at checkout, with returning customers using DOSE25.
Unlike competitors charging separate consultation fees, our prices include everything: 3-minute online clinical assessment, prescriber review within 3 working days (express 24-hour available), and next-day cold-chain delivery. When comparing Ozempic vs Wegovy vs Mounjaro costs, this transparency eliminates the anxiety of unexpected charges appearing during checkout.
Clinical Evidence: Ozempic vs Wegovy vs Mounjaro Mechanisms
Understanding Ozempic vs Wegovy vs Mounjaro requires recognising their different mechanisms and licensing. Wegovy (semaglutide) is a GLP-1 receptor agonist, whilst Mounjaro (tirzepatide) targets both GIP and GLP-1 receptors. In clinical trials, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks (Wilding et al., NEJM, 2021).
Mounjaro's dual-hormone approach showed different trial results, though direct comparison between Ozempic vs Wegovy vs Mounjaro efficacy requires considering different trial designs and patient populations. Both are prescription-only medicines requiring clinical assessment to determine suitability for individual patients.
How Wegovy Works in the Ozempic vs Wegovy vs Mounjaro Comparison
Wegovy functions as a GLP-1 receptor agonist, mimicking your body's natural fullness hormone to reduce appetite and promote satiety after smaller meals. This mechanism may help reduce food cravings by working on brain appetite centres, supporting weight management alongside a reduced-calorie diet and increased physical activity. Unlike Ozempic (licensed for diabetes), Wegovy is specifically approved for weight management in eligible adults. The once-weekly FlexTouch pen injection offers convenient dosing, starting at 0.25mg and escalating gradually to the 2.4mg maintenance dose over 17 weeks.
Streamlined Ordering: No Hidden Assessment Fees
Our transparent process for Ozempic vs Wegovy vs Mounjaro begins with a 3-minute online clinical assessment, included in your medication price. Our GPhC-registered prescribers (pharmacy #9012878) review your application within 3 working days, with express 24-hour review available for urgent requirements. Once approved, next-day delivery ensures your prescription-only medicine arrives via temperature-controlled cold-chain transport. No surprise consultation fees, prescription charges, or delivery costs appear at checkout - the price you see includes comprehensive clinical care and logistics.
Storage and Practical Considerations
When comparing Ozempic vs Wegovy vs Mounjaro practically, storage requirements differ significantly. Wegovy requires refrigeration at 2-8°C before first use but offers 6 weeks at room temperature (below 30°C) once removed - a considerable advantage over Mounjaro's 21-day room temperature limit. The FlexTouch pen design ensures accurate dosing throughout the mandatory dose escalation schedule: 0.25mg (weeks 1-4), 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), and 2.4mg maintenance from week 17 onwards. This gradual increase helps minimise potential side effects whilst optimising treatment effectiveness.
Why Transparent Pricing Matters for Ozempic vs Wegovy vs Mounjaro Decisions
Hidden fees deliberately obscure the true cost of comparing Ozempic vs Wegovy vs Mounjaro, preventing informed treatment decisions. Many patients abandon their weight management journey when unexpected charges appear, particularly when monthly costs exceed budgeted amounts. Our transparent pricing eliminates this barrier, allowing genuine cost comparison between treatment options.
This honesty extends beyond pricing to clinical transparency - we clearly explain that Ozempic vs Wegovy vs Mounjaro aren't interchangeable choices since Ozempic isn't licensed for weight management in the UK. Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which prescription-only medicine aligns with your clinical needs and treatment goals.
Start Your Weight Management Journey Today
Begin comparing Ozempic vs Wegovy vs Mounjaro with complete price certainty at EverydayMeds. Our £79.99 Wegovy starter dose includes everything needed for safe, legal treatment: clinical assessment, prescriber review, prescription, and cold-chain delivery to your door. New customers use code FIRST40 at checkout, whilst returning patients apply DOSE25 for continued transparent pricing. Visit our Wegovy collection at https://everydaymeds.co.uk/collections/wegovy to begin your clinically-supervised weight management programme. Our GPhC-registered pharmacy (#9012878) ensures you receive genuine, properly stored medication with comprehensive clinical oversight throughout your treatment journey.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
